Introduction

Follicular helper T cells (Tfh cells) are a particular subpopulation of CD4
+ T cells that is critically required for the activation of follicular B cells. Since their identification as a discrete CXCR5 + subset specialized in collaborating with B cells (Schaerli et al., 2000; Breitfeld et al., 2000; Kim et al., 2001) , and the identification of the repressor Bcl6 as the master regulator transcription factor of this subset (Johnston et al., 2009; Nurieva et al., 2009; X. Liu et al., 2009) , a large body of research has helped to understand their activation requirements and the differential signals underlying their communication with B cells (Crotty, 2014; Vinuesa et al., 2016) . Both soluble factors (i.e. cytokines) and cell surface molecules have been shown to act in parallel to orchestrate this communication. Moreover, several of these signals have been proposed as candidate targets for immunotherapeutic interventions to treat diseases in which B-cell responses are relevant (Hu et al., 2013; Spolski and Leonard, 2014) . However, the relative impact of these different types of signals on the outcome of infection or disease remains poorly explored. The Signaling Lymphocytic Activation Molecule (SLAM)-Associated Protein (SAP) is a small intracellular adaptor protein, which interacts with the cytoplasmic tails of the SLAM family of cell surface receptors and mediates signaling downstream of these receptors (Cannons et al., 2011) . Mutations in SAP were originally associated with most cases of X-linked lymphoproliferative syndrome (Cannons et al., 2011) . One outstanding function of SAP is to mediate signaling leading to the stable long-duration contact of T and B cells (Qi et al., 2008) . This physical interaction between T and B cells, tightly regulated by SAP, has been shown to be critical for the activation of germinal center (GC) B-cells (Qi, 2012) , and the activation of Tfh cells in some models (Cannons et al., 2010; Deenick et al., 2010; Linterman et al., 2011) .
The B-cell response to the blood stages of Plasmodium, the protozoan parasite that causes malaria, is thought to be important for protective immunity in human infections (Cohen et al., 1961; Conway et al., 2000; Fowkes et al., 2010; Osier et al., 2008; Sabchareon et al., 1991) . B cells and antibodies are also necessary for the elimination of this stage of infection in experimental mouse models (Burns et al., 1997; von der Weid et al., 1996) ; thus, these models allow an examination of the relative importance of different Tfh-derived signals in the control of infection. Dysfunctional Tfh responses have been described in children exposed to P. falciparum, which are thought to be responsible for impaired development of protective B cell-responses (Obeng-Adjei et al., 2015) . P. berghei infection in mice inhibits Tfh differentiation (RygCornejo et al., 2015) , whereas boosting of Tfh responses in mice by therapeutic interventions has been shown to accelerate the control of chronic P. chabaudi infection (Butler et al., 2012) . The critical signals EBioMedicine 24 (2017) [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] required for Tfh activation to Plasmodium infection have also begun to emerge. OX40, PD-1 and ICOS cell surface molecules were shown to regulate Tfh activation during non-lethal P. yoelii and P. chabaudi infections (Zander et al., 2015; Wikenheiser et al., 2016) . We have recently shown that IL-21-producing CD4 + T cells, of which a substantial proportion has a Tfh cell phenotype, are required to activate IgG responses to P. chabaudi and to control the chronic phase of this infection (Pérez-Mazliah et al., 2015) . Interestingly, acute gamma herpes virus co-infection leads to loss of control of an otherwise non-lethal P. yoelii infection, and this is associated with a disruption of the Tfh cell response (Matar et al., 2015) . Despite these important advances in our knowledge of Tfh cell responses, a direct link between Tfh cell responses and the control of Plasmodium infection remains to be demonstrated, and the relative impact of the different Tfh-derived signals (i.e. cell surface molecular interactions vs soluble factors) on the control of the infection has not been explored in detail. Moreover, despite the substantial differences in infections initiated by artificial versus natural mosquito transmission (Spence et al., 2013) , our knowledge of T-and B-cell responses during experimental erythrocytic malaria models has been exclusively generated using artificial injection of infected blood to initiate the infection, thus obviating the full life cycle in the mouse. Here, using both blood transmission as well as a model of natural mosquito transmission, we compared the relative requirements of Tfh responses overall, together with the individual requirements of SAP and IL-21R on the control of Plasmodium chabaudi AS infection, a rodent model which presents both an acute and chronic phase (Achtman et al., 2007) .
We demonstrate a critical role for Tfh cells in the elimination of the chronic phase of Plasmodium infection initiated by both, blood transmission, and natural mosquito transmission. In addition, and contrary to previous observations in immunization studies, and virus and helminth infections (Crotty et al., 2003; Cannons et al., 2006; Kamperschroer et al., 2006; Crotty et al., 2006; McCausland et al., 2007; Moyron-Quiroz et al., 2009; Yusuf et al., 2010; Morra et al., 2005) , we show that SAP-deficient mice are able to activate Tfh and GC B cells, and an IgG response to the parasite. Finally, we demonstrate a hierarchy of immune responses needed to control the magnitude of the chronic infection, with IL-21 signaling being the most significant requirement followed by Tfh cells and SAP. Our data demonstrate the need for a fully functioning Tfh response for elimination of blood-stage Plasmodium infection, and highlights substantial differences in the signals required to activate Tfh and GC B cell responses to this complex parasite compared to immunizations and other infection models.
Materials and Methods
Ethical Statements
All scientific experiments involving procedures on mice were approved by the Ethical Review Panel of the MRC National Institute for Medical Research (NIMR). They were performed accordingly to the UK National guidelines of the Animals (Scientific Procedures) Act 1986 under the license reference number PPL 70/8326 authorized and granted by the British Home Office.
Mice
C57BL/6, Sh2d1a (Wu et al., 2001) (Shinkai et al., 1992) , RRID:MGI:3617415] mouse strains were bred in the specific pathogen-free facilities of the Mill Hill Laboratory of the Francis Crick Institute, and were backcrossed for at least 10 generations onto NIMR C57BL/6 mice. For experimental use, 6-12 weeks old female mice were housed in conventional facilities with sterile bedding, food and water under reversed light conditions (dark: 7.00 h to 19.00 h).
Infections
Plasmodium chabaudi chabaudi (AS) was originally obtained from David Walliker, University of Edinburgh. Infections were initiated by intraperitoneal injection of 10 5 infected red blood cells, or by the bites of infected A. stephensi mosquitoes as previously described (Spence et al., 2012) . Blood-stage parasitemias were monitored by Giemsa-stained thin blood smears (Langhorne et al., 1989) .
Flow Cytometry
Spleens were dissected and mashed through 70 μm filter mesh in Hank's Balanced Salt Solution (HBSS, Gibco, Invitrogen) to generate single cell suspensions. Spleens were treated in RBC lysis buffer (Sigma) and remaining cells resuspended in complete Iscove's Modified Dulbecco's Medium (IMDM supplemented with 10% fetal bovine serum (FBS) Serum Gold (PAA Laboratories, GE Healthcare), 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100 U penicillin, 100 mg streptomycin, 6 mM Hepes buffer, and 50 mM 2-ME (all from Gibco, Invitrogen). Viable cells were counted based on trypan blue (Sigma) exclusion in a hemocytometer. 2 × 10 6 viable cells were distributed to each well of a 96-well plate (Nunc) and incubated in the presence of a monoclonal anti-mouse CD16/32 antibody (Unkeless and Unkeless, 1979 , BioLegend Cat# 101318 RRID:AB_2104156) to block Fc-mediated binding of antibodies for 20 min at 37°C, 20 min at 4°C. To identify Tfh cells, cells were first incubated with biotin anti-CXCR5 (BD Biosciences Cat# 551960 RRID:AB_394301) in complete IMDM (BD Pharmingen), washed twice with a staining buffer (1× PBS (pH = 7.2-7.4), 2% FBS, 0.01% Sodium azide), resuspended in 1 × PBS and incubated with appropriate dilutions of PE streptavidin, APC-Cy7 anti-CD4 (BioLegend Cat# 100414 RRID:AB_312699), PE-Cy7 anti-PD-1 (BioLegend Cat# 109110 RRID:AB_572017), Pacific Blue anti-CD3, PerCP-Cy5.5 or FITC anti-CD44 (BioLegend) for 30-40 min at 4°C. A commercial kit (eBioscience) was used for intra-nuclear detection of Bcl6, following manufacturer's instructions, and using the anti-human and mouse Bcl-6 antibody conjugated to Alexa Fluor 647 (BD Biosciences Cat# 561525 RRID:AB_10898007).
To identify germinal center Tfh and B cells, spleen cells were incubated with appropriate dilutions of PerCP-Cy5.5 anti-CD3 (BioLegend Cat# 100328 RRID:AB_893318), PE anti-CD4 (BioLegend Cat# 100408 RRID:AB_312693), PE-Cy7 anti-CD45R/B220 (BioLegend Cat# 103222 RRID:AB_313005), APC-Cy7 anti-CD19 (BioLegend Cat# 115530 RRID:AB_830707), APC anti-CD38 (BioLegend Cat# 102712 RRID:AB_ 312933) FITC anti-GL-7 (BioLegend Cat# 144604 RRID:AB_2561697) and BV421 anti-IgD (BioLegend Cat# 405725 RRID:AB_2562743) for 30-40 min at 4°C. Germinal center B cells were identified by combined expression of CD19 and B220, low expression of IgD and CD38, and high expression of GL-7. Tfh cells were identified by the combined expression of CD3, CD4 and GL-7. T-B cell conjugates were studied ex vivo by flow cytometry as previously described (Reinhardt et al., 2009 ). Conjugates were identified by the combined expression of CD3, CD4, CD19 and B220, and identified as doublets based on FSC-A vs FSC-W.
IL-21 detection by flow cytometry was done by intracellular staining as previously described (Pérez-Mazliah et al., 2015) .
All cells were fixed with 2% paraformaldehyde for 15 min at 4°C, washed and stored in the staining buffer at 4°C until acquisition. Cells were acquired on BD FACSVerse, BD LSRII or BD LSRFortessa X-20 (BD Biosciences) flow cytometers. Dead cells were excluded by staining with LIVE/DEAD Aqua (Invitrogen) prior fixation. Fluorescence-minusone (FMO) controls were used to set the thresholds for positive/negative events. Analysis was performed with FlowJo software version 9.6 or higher (Tree Star). Doublets based on side scatter light and forward scatter light Area vs Width were routinely excluded from the analysis, with the exemption of the assay to study T-B cell conjugates, in which doublets were deliberated included in the analysis.
Histology
Spleens were dissected and fixed for 24 h in 10% neutral buffered formalin (Sigma), embedded in wax, sectioned (4 μm), and stained by incubating with rat Anti-mouse CD45R/B220 (BD Biosciences Cat# 550286 RRID:AB_393581), rabbit anti CD3G (Abcam Cat# ab108996 RRID:AB_10862885), biotinylated peanut agglutinin (PNA, Vector Laboratories Cat# B-1075 RRID:AB_2313597), followed by incubation with goat anti-rat IgG alexa fluor 647 (Molecular Probes Cat# A-21247 also A21247 RRID:AB_141778), goat anti-rabbit IgG alexa fluor 488 (Molecular Probes Cat# A-11008 also A11008 RRID:AB_143165), streptavidin alexa fluor 555 (ThermoFisher), and DAPI (ThermoFisher). Stained sections were scanned on a ZEISS Axio Scan.Z1 with ZEN 2 software (Zeiss). Area, perimeter and number of PNA + GC were determined with Fiji (Schindelin et al., 2012) .
P. chabaudi-specific ELISAs
Serum samples were obtained periodically after P. chabaudi infection by bleeding the mice from the tail vein. Whole parasite lysate was generated and used in ELISAs to measure specific IgM, IgG and IgG subclasses, as previously described (Quin and Langhorne, 2001) , with the SBA Clonotyping System-C57BL/6-HRP (SouthernBiotech Cat# 5300-05B). A pool of plasma from NIMR C57BL/6 mice challenged at least six times with P. chabaudi was used as a standard for each isotype, and defined as 1000 arbitrary units (AU). The amounts of each isotype were calculated in AU derived from this standard, which was run in parallel with every experimental sample assayed.
Statistical Analysis
Statistical analyses were performed using Mann Whitney U test, Kruskal-Wallis test with Dunn's multiple comparisons test, two-way ANOVA with Tukey's multiple comparisons test, or Chi-square test on Prism v7 (GraphPad). P b 0.05 was accepted as a statistically significant difference.
Results
Bcl6
fl/fl and SAP-deficient Mice; Two Different Models to Explore the
Role of Tfh Responses During P. chabaudi Infection
The repressor Bcl6 has been identified as the master transcription factor regulating the Tfh cell program (Johnston et al., 2009; Nurieva et al., 2009; X. Liu et al., 2009 ). In addition, SAP (encoded by the Sh2d1a gene) has been shown to signal directly in CD4 + T cells and to regulate Tfh cell activation in some immunization models (Cannons et al., 2010; Deenick et al., 2010; Linterman et al., 2011 CD4-cre +/− mice failed to control or eradicate the chronic phase of infection, and showed parasitemias variably around 1% iRBC for the duration of the experiment (parasitemias of individual mice are shown in right hand graph of Fig. 1a ). During this time, wt mice had reduced parasitemias to b0.001% (i.e. below detection limit, Fig. 1a ). Importantly, similar patterns of acute and chronic infection were also observed in Bcl6 fl/fl CD4-cre +/− mice infected via mosquito bites rather than by direct injection of iRBC (Fig. 1b) . The lack of SAP had a more moderate, yet detectable, effect on the P. chabaudi infection. The acute infection in both Sh2d1a −/− and wt C57BL/ 6 mice was similarly reduced to b0.1% by day 18 (Fig. 2a) . Although chronic parasitemias were initially higher in all Sh2d1a −/− mice than in wt mice, parasitemias were very variable between individual mice. Eventually by 110 days p.i. all wt C57BL/6 mice had undetectable parasitemias (i.e. b 0.001%), and only 2/8 of the Sh2d1a −/− mice showed detectable parasitemias ( Fig. 2a) , suggesting clearance of infection in all wt controls and the majority of Sh2d1a −/− mice. However, a technique more sensitive to detect parasitemia, i.e. transfer of 100 μl of blood from Sh2d1a −/− and wt mice at this time into Rag2 −/− mice, demonstrated that 50% of these Sh2d1a −/− mice were still sub-patently infected, whereas confirming that all wt C57BL/6 mice had cleared their infection (Table 1) . Thus, these data demonstrate that although there is significant control of the chronic infection, SAP signaling is required for the complete elimination of the P. chabaudi infection. Importantly, a similar pattern of chronic infection was observed in mice infected via mosquito bites rather than by direct injection of iRBC (Fig. 2b) .
Altogether, these data demonstrate that the inactivation of the Bcl6 gene in T cells, encoding the Tfh program, has a dramatic effect in the control of chronic Plasmodium infection, and unexpectedly more pronounced compared to the lack of SAP signaling.
Bcl6, but not SAP, is Required for the Initial Tfh Cell Response to P. chabaudi Infection
As both Bcl6 and SAP have been shown to be required for fully functional Tfh responses, we then studied the activation of Tfh cell responses to P. chabaudi in Bcl6 Fig. 3a-b ). Tfh cells can be alternatively identified by the combined expression of CXCR5 and Bcl6 (Choi et al., 2011) . Using this alternative phenotypic definition of Tfh, we confirmed no expansion of to the levels detected in similarly infected wt C57BL/6 control mice (Fig. S1 ).
In agreement with previous publications (Wu et al., 2001; Czar et al., 2001; Kaji et al., 2012) , nor Sh2d1a −/− mouse strains showed significant alterations in the activation of T-bet + CD4 + Th1 responses during this strong Th1-biased P. chabaudi infection (Fig. S3 ). These data demonstrate that the initial Tfh cell response to P. chabaudi can be activated even in the absence of SAP signaling, in contrast to infected Bcl6 fl/fl CD4-cre + mice, in which Tfh cells were lacking.
The Lack of Tfh Cells and Deficiency of SAP Differentially Impact the Activation of GC B-cells in Response to P. chabaudi Infection
We have previously shown that robust GC B-cell responses to P. chabaudi infection in the spleen of C57BL/6 mice are readily detected at days 14-40 p.i. (Pérez-Mazliah et al., 2015; Achtman et al., 2003) . In the absence of Tfh-cell responses, Bcl6 iRBC (a), or bites from P. chabaudi-infected mosquitoes (b), and parasitemias were periodically monitored by giemsa-stained thin blood smears. The course of acute (left column) and chronic (right column) infection is displayed. The acute phase is displayed as median + range, while curves corresponding to individual mice are displayed for the chronic phase. Data are representative of at least two independent experiments and were obtained in groups of 7-8 mice per time point. Statistical significance was obtained using Mann Whitney U test.
Table 1
Number of parasitemic C57BL/6 and Sh2da1 −/− blood donors (N100 p.i.), and parasitemic Surprisingly, although the number of GC B-cells activated in the spleen of infected SAP-deficient mice was reduced compared with wt C57BL/6 controls, these mice were still able to activate a distinctive GC B-cell response to P. chabaudi infection, readily detectable by flow cytometry by day 35 p.i. (Fig. 4 c-d ). In accordance, GC structures were readily detected in spleen sections of SAP-deficient mice by day 35 p.i. (Fig. 4 E) , although at reduced numbers and size compared with wt C57BL/6 controls (Fig. 4 F) . These data show that GC B-cell responses take place in the absence of SAP, and highlight substantial differences in the signaling network leading to GC activation in response to Plasmodium compared with GC responses after immunizations or in other infection models. 3.4. The GC Tfh Cell Responses to P. chabaudi are Affected, but not Entirely Abrogated, in the Absence of SAP Signaling
The activation of a particular subset of CD4 + Tfh cells which homes into germinal centers (GC Tfh), has been shown to follow the initial activation of Tfh-cell responses, to express the germinal center marker GL-7, to be critical for GC B-cell activation, and to require SAP signaling for its activation (Yusuf et al., 2010) . We therefore examined the activation of GC Tfh cells in the spleen during P. chabaudi infection.
As anticipated by the absence of early Tfh responses to P. chabaudi infection in Bcl6 fl/fl CD4-cre +/− mice, no GC Tfh cells were detected above background level at any time point post P. chabaudi infection in these mice (Fig. 5 a-b) . On the other hand, although reduced compared to wt C57BL/6 controls, a GC Tfh cell response to P. chabaudi was readily detected by flow cytometry by day 35 p.i. in Sh2d1a −/− mice (Fig. 5 c-d ).
The occurrence of GC Tfh cells in the absence of SAP was further confirmed by the detection of T cells inside the GC structures in the spleen, as determined by histology (Fig. 5 e-f ). These data demonstrate that, although the initial activation of Tfhcell responses to P. chabaudi showed no major alterations in SAP-deficient mice, this signal is indeed required later in the infection for full activation of a GC Tfh-cell response, and further support a requirement for fully functional Tfh-dependent B-cell activation to eradicate Plasmodium infection.
3.5. The B-T Cell Interactions in the Spleen are Affected, but not Entirely Abrogated, in the Absence of SAP Signaling During P. chabaudi Infection SAP signaling is required for stable B-Tfh cell interactions, which are thought to be necessary for activation of GC B-cell responses (Qi, 2012) . Given the unexpected presence of GC Tfh and GC B cells in the absence of SAP signaling in the P. chabaudi infection, we asked whether stable B-T cell conjugates could form in the spleen during P. chabaudi infection.
To study this, we used a method previously described (Reinhardt et al., 2009) (Fig. 6a) . The numbers of B cell-CD4 + T cell conjugates were not significantly altered in Sh2d1a −/− mice compared with wt C57BL/6 controls either at day 15 or 35 p.i. (Fig. 6 b-c) . However, the number of conjugates containing GC B cells (CD3 + CD4 + CD19 + B220 + CD38 + GL-7 + ), at day 35 p.i., were significantly lower in Sh2d1a −/− mice compared with wt C57BL/6 controls at this time ( Fig. 6 d-e) . Albeit reduced, these interactions were still able to occur in SAP-deficient mice, as the number of GC B-CD4 + T cell conjugates in these mice was significantly higher at day 35 p.i. compared with background level (Fig. 6 d- 
e). As expected, Bcl6
fl/fl CD4-cre +/− mice showed a significantly reduced number of B-T cell conjugates compared with Bcl6 fl/fl control mice at day 35 p.i. (Fig. 6 f-g ), and no GC B-CD4 + T cell conjugates above background level at any time point studied (Fig. 6 h-i) .
Thus, the lack of Tfh-cell responses render mice unable to sustain stable GC B-CD4 + T cell interactions, while the lack of SAP signaling impairs, but does not entirely abrogate, these important interactions.
The Lack of Tfh Cells and Deficiency of SAP Differentially Impact the Activation of P. chabaudi-specific IgG Responses
The GC response is a major source of antibody class switching. Therefore, we hypothesized that the differential impact in GC responses to P. chabaudi due to absence of SAP signaling or Tfh responses altogether might be translated in a differential impact on the IgG response to the parasite. This, in turn, could explain the differential capacity of Bcl6 In the absence of Tfh cells and GC B-cells, Bcl6 fl/fl CD4-cre +/− mice were unable to produce all subtypes of P. chabaudi-specific IgG antibodies ( Fig. 7 a, c, e and g), whereas P. chabaudi-specific IgM responses were not altered up to day 35 p.i., and still detectable at day 126 p.i., in these mice (Fig. 7i) . P. chabaudi-specific IgG responses were more variable in Sh2d1a −/− mice; IgG2c antibodies were the most affected, while P.
chabaudi-specific IgG1 and IgG3, as well as IgM, showed delayed kinetics in Sh2d1a −/− mice compared with the antibody response of wt C57BL/6 control mice (Fig. 7 b, d , f, h and j). Therefore, both IgG and IgM responses were affected, but not completely abrogated by the lack of SAP signaling. These data demonstrate that P. chabaudi-specific IgM responses can still be activated in the absence of Tfh responses, and that even partial alterations in P. chabaudi-specific IgG responses, as seen in SAP-deficient mice, are associated with reduced capacity to control this infection.
What Contributes to the Control of P. chabaudi Infection in the Absence of Tfh Cells?
Although the Bcl6 fl/fl CD4-cre +/− mice, completely deficient in Tfh cell
and GC B-cell responses, failed to eradicate chronic P. chabaudi infection, these mice did not succumb to the infection, similar to mice with a complete deficiency of B cells do not succumb to P. chabaudi infection (von der Weid et al., 1996) . These data strongly suggest that there is an additional immune component that, although not being able to eradicate the infection, is capable of controlling P. chabaudi to some extent. We have previously shown that μMT mice, deficient in B cells, undergo a dramatic expansion of the number of γδT cells in the spleen in response to P. chabaudi infection (von der Weid et al., 1996) . Similarly, Bcl6 fl/fl CD4-cre +/− mice showed increased number of γδT cells in the spleen during the chronic phase of infection (Fig. 8 a-b) . However, this was not the case for Sh2d1a −/− mice (Fig. 8 c-d We have recently shown that IL-21 is critical to activate protective Bcell responses to Plasmodium infection (Pérez-Mazliah et al., 2015) . Similar to Bcl6 fl/fl CD4-cre +/− and Sh2d1a −/− mice, Il21r −/− mice had an initial course of acute P. chabaudi infection with peak parasitemias at days 8-9 (Fig. 9 a-b) . Also, similar to Bcl6 fl/fl CD4-cre +/− and Sh2d1a −/− mice and unlike wt C57BL/6 controls, Il21r −/− mice failed to reduce (right column) and respective wt control mice were infected with P. chabaudi via intra peritoneal injection of 10 5 iRBC, and the levels of P. chabaudi-specific IgG1 (a-b), IgG2b (c-d),
IgG2c (e-f), IgG3 (g-h) and IgM (i-j) were determined in serum samples by ELISA. Bars represent median values. Data are pooled from two independent experiments and were obtained in groups of 3-5 mice per time point. Statistical significance was obtained using Two-Way ANOVA with Tukey's multiple comparisons test.
parasitemia during the chronic phase, and the infection remained at levels between 10 and 50% from day 15 p.i. up to the 110 days of the experiment, without mortality [Fig. 9 a-b and (Pérez-Mazliah et al., 2015) ]. These chronic parasitemias were notably higher than the chronic parasitemias observed in either Bcl6 fl/fl CD4-cre +/− and Sh2d1a −/− mice ( Fig. 9 c-d) . Thus, intriguingly, it appears that IL-21 has a role in controlling P. chabaudi infection beyond Tfh-dependent B-cell activation. In accordance with this hypothesis, we have previously shown that the CD4 + T cell compartment producing IL-21 in response to P. chabaudi was approximately equally composed of Tfh and non-Tfh CD4 + T cells, and exclusively detected during acute infection (Pérez-Mazliah et al., 2015) . In agreement, despite complete absence of Tfh cell activation, IL-21-producing CD4 + T cells were still activated in P. chabaudi-infected Bcl6 fl/fl CD4-cre +/− mice (Fig. 10) .
Moreover, as predicted, the number of IL-21-producing CD4 + T cells detected at the peak of infection in Bcl6 fl/fl CD4-cre +/− mice was reduced to approximately half the amount of these cells in wt controls, thus showing that the Tfh response represents an important, but not the only, source of IL-21 during P. chabaudi infection (Fig. 10) . In summary, we show that different signals previously implicated in B-T cell communication differentially impact the control of chronic P. chabaudi infection, following a gradient: IL-21 deficiency N Tfh deficiency N SAP deficiency.
Discussion
Our study formally demonstrates an essential requirement of Tfh cells to eradicate a chronic systemic Plasmodium infection initiated by natural vector transmission. In addition, we highlight substantial differences in the signaling network leading to GC activation in response to Plasmodium compared to immunizations or other infection models.
The effects of natural transmission by the mosquito in experimental models have generally been overlooked in studies of immune mechanisms elicited to blood-stage Plasmodium infection. However, immune responses, in particular B-cell responses, elicited to the less physiological injection of Plasmodium-infected red blood cells can differ from those elicited by natural transmission (Spence et al., 2013) . Therefore, the natural vector route is an important component of the experimental system for host responses to Plasmodium parasites. Here, we validated all the responses observed using models of natural mosquito transmission.
Previous studies both in human and mouse models have shown the importance of B cell-responses to control Plasmodium infection (Cohen et al., 1961; Conway et al., 2000; Fowkes et al., 2010; Osier et al., 2008; Sabchareon et al., 1991; Burns et al., 1997; von der Weid et al., 1996) . The signals required to activate protective B-cell responses to this infection have recently started to emerge. Tfh cells have been identified as the critical CD4 + T helper subset required for activation of follicular B-cell responses (Schaerli et al., 2000; Breitfeld et al., 2000; Kim et al., 2001) . Recent evidence has suggested that Plasmodium infection has the capacity to bias the CD4 + T cell response toward a predominantly IFN-γ-producing Th1 response and consequently impair Tfh cell differentiation resulting in poor B-cell responses to the parasite (Hansen et al., 2017) . Nonetheless, both Tfh cell and GC B-cell responses are strongly activated in a number of Plasmodium models (Zander et al., 2015; Matar et al., 2015; Achtman et al., 2003 ; Pérez-Mazliah et al., 2015; Wikenheiser et al., 2016) , and in P. chabaudi infections these are not impaired by the activation of a strong Th1 response (Pérez-Mazliah et al., 2015; Wikenheiser et al., 2016) . Herein, we investigated the requirement of Tfh cells to control Plasmodium infection in the P. chabaudi model. We focused on the transcription repressor Bcl6, the master regulator of the Tfh program (Johnston et al., 2009; Nurieva et al., 2009; X. Liu et al., 2009) , and on the SAP molecule, previously shown to be required for B-Tfh cell interactions (Qi et al., 2008) , and the activation of GC B-cells (Crotty et al., 2003; Cannons et al., 2006; Kamperschroer et al., 2006; Crotty et al., 2006; McCausland et al., 2007; Moyron-Quiroz et al., 2009; Yusuf et al., 2010; Morra et al., 2005) and Tfh cells in some models (Cannons et al., 2010; Deenick et al., 2010; Linterman et al., 2011 
Sh2d1a1
−/− mice compared with C57BL/6 controls. The fact that the lack of SAP signaling did not disrupt the initial Tfh cell response to P. chabaudi seems to contradict some observations (Cannons et al., 2010; Deenick et al., 2010; Linterman et al., 2011) . However, other works reported activation of Tfh cells in the absence of SAP, using both immunizations (Qi et al., 2008) and LCMV infection (Yusuf et al., 2010) . Moreover, Deenick et al. demonstrated that the defect on Tfh activation in the absence of SAP occurs when the availability of antigen is limited, and can be rescued by boosting with antigen (Deenick et al., 2010) . Therefore, the requirement of SAP for Tfh activation seems to be context-dependent, and the consensus in the field is now that SAP is not required for the initial activation of the Tfh program, but rather for the maintenance of this program and the relocalization of the Tfh cells into the germinal center (Crotty, 2014; Qi, 2012) . This agrees with our observation of reduced, yet detectable, CD4 + GL7 + GC Tfh cells in the spleen of P. chabaudi-infected Sh2d1a1 −/− mice. Our observations of unaltered CD4 + T-B cell conjugates yet altered CD4 + T-GC B cell conjugates in Sh2d1a1 −/− mice compared with wt C57BL/6 controls, is in line with the long-lasting T-B cell interactions in the T-cell zone and follicle border and progressively shorter contact durations (and, therefore, more sensitive to mechanical disruption) inside the follicles and germinal centers observed in immunizations (T. Okada et al., 2005; Qi et al., 2008; Allen et al., 2007; Kerfoot et al., 2011; Shulman et al., 2014; D. Liu et al., 2015) . On the other hand, SAP-deficient mice fail to activate GC B-cell responses to immunizations with T-dependent antigens, viral infections, and helminth infections (Crotty et al., 2003; Cannons et al., 2006; Kamperschroer et al., 2006; Crotty et al., 2006; McCausland et al., 2007; Moyron-Quiroz et al., 2009; Yusuf et al., 2010; Morra et al., 2005) . Therefore, it is indeed surprising that SAP-deficient mice can activate, albeit significantly reduced, a distinctive GC response to P. chabaudi. This is demonstrated by the occurrence of a) CD38 low GL7 + GC B cells, b) GC structures as determined by histology c) GL7 + CG Tfh cells, d) T cells within the GC as determined by histology, e) stable T-GC B cell conjugates and f) P. chabaudi-specific IgG responses in Sh2d1a1 −/− mice. The deficient T-B cell interaction driven by the absence of SAP can be partially compensated by other signals, i.e. strong cognate interactions in the context of high antigen availability on B cells (Qi, 2012; Qi et al., 2008) . Thus, these mechanisms might be in place during P. chabaudi infection and able to partially compensate for the lack of SAP signaling. P. chabaudi infection is the only infection model identified to date in which GC B cells can be activated in the absence of SAP. A recent report by Wikenheiser et al. shows that ICOS is dispensable during early Tfh cell differentiation in response to P. chabaudi infection, but it is required for sustaining the Tfh cell response over time (Wikenheiser et al., 2016) . Interestingly, both P. chabaudispecific B-cell responses and the course of P. chabaudi infection in ICOS-deficient mice resemble our observations in SAP-deficient mice more closely than in Bcl6 fl/fl CD4-cre +/− mice (i.e. partial, but not complete, abrogation of the GC B cell response and P. chabaudi-specific IgG responses, and highly variable control of the parasitemia late during chronic infection) (Wikenheiser et al., 2016) . ICOS engagement promotes persistent T-cell migration at the border between the T-cell zone and the B-cell follicle, and controls follicular recruitment of activated T-helper cells independently from the ICOSL-mediated co-stimulation provided by cognate B cells, thus acting as a molecular linkage between T-B cells (Xu et al., 2013; D. Liu et al., 2015; Qi, 2016) . Therefore, it is possible that SAP and ICOS act via a similar mechanism during P. chabaudi infection, i.e. via regulating T helper cell positioning in the follicle and favoring T-B cell interactions, and can partially compensate for each other. Notably, the deficiency of ICOS signaling reduced GC B-T cell interactions during P. chabaudi infection, similarly to SAP deficiency (Wikenheiser et al., 2016) . This inefficient, yet distinctive, GC activation in Sh2d1a1 −/− mice can explain the better control of the infection by these mice compared with the complete absence of Tfh cell responses in Bcl6
fl/fl CD4-cre +/− mice, and strongly supports a model in which the quality of the T-dependent B cell response reflects the capacity to control the blood stages of P. chabaudi infection.
In conclusion, here we provide evidence of the major role of Tfh cell responses in controlling and clearing the chronic phase of Plasmodium infection. In addition, we delineate a hierarchical requirement of signals previously associated with T-B cell interactions in the control of this infection, following the order IL-21 N Tfh cells N SAP. This proved to be true for both, blood and natural mosquito transmission of P. chabaudi infection. Intriguingly, these data suggest a role for IL-21 beyond B cell activation driven by Tfh cells. In agreement with this, c-Maf, but not Bcl6, is known to control IL-21 expression (Bauquet et al., 2009; Hiramatsu et al., 2010; Kroenke et al., 2012) , and non-Tfh IL-21-producing CD4 + T cells are detected during P. chabaudi infection (Pérez-Mazliah et al., 2015; Carpio et al., 2015) and P. berghei ANKA infection (Ryg-Cornejo et al., 2015) . Therefore, further research is needed to determine the full role of this pleiotropic cytokine in the control of this infection. Monitoring of both IL-21 and Tfh responses have generally not been included in studies aimed at generating protective vaccines to Plasmodium infection. In the light of data presented herein, monitoring of both of these critical immune signals should be considered when evaluating the efficacy of novel immune therapies designed to prevent or eliminate Plasmodium infection.
Our data complete the study of a battery of fundamental signals implicated in T-B cell interactions in the context of blood-stage Plasmodium infection, i.e. PD-1 (Butler et al., 2012; Zander et al., 2015) , IL-21 (Pérez-Mazliah et al., 2015) , OX40 (Zander et al., 2015) and ICOS (Wikenheiser et al., 2016) . Altogether, these data provide a framework to weigh the relevance of different signals regulating T-B cell interactions for the control of this complex parasite, which is critical to reach the goal of generating protective immunotherapies to control the spread of malaria.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ebiom.2017.08.030.
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